生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Flumequine (R-802) acts as a topoisomerase II inhibitor, with an IC50 of 3.92 μg/mL, and inhibits Gyrase less effectively, with an IC50 of 1764 μg/mL. Flumequine (0-625 μg/mL) leads to increased migration of nuclear DNA from CHL cells[1]. Flumequine (R-802) effectively inhibits Spanish field isolates of B. hyodysenteriae with MIC50 and MIC90 of 50 and 100 μg/mL, and MBC50 and MBC90 of 50, 200 μg/mL, respectively[2]. Flumequine (R-802) inhibits A. salmonicida isolates with MIC values ranging from 0.06 to 32 μg/mL[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02068664 | - | Completed | - | United States, New Jersey ... 展开 >> Adler Aphasia Center Maywood, New Jersey, United States, 07607 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.83mL 0.77mL 0.38mL |
19.14mL 3.83mL 1.91mL |
38.28mL 7.66mL 3.83mL |
参考文献 |
---|